Dyadic International, Inc.
NASDAQ:DYAIBiotechnology
+$0.26 today
- Market cap
- $53.56M
- Beta
- 1.15
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.20
Volume 0.71M
Average 0.31M
DYAI Debt Repayment
Cash used to repay borrowings during the period.
Dyadic International, Inc.NASDAQ: DYAI
Debt Repayment · Q1 FY2026 · quarter ended Mar 2026
Debt repayment outflow grows to $0
Q1 FY2026 debt repayment was $0, compared with $0 a year earlier. Trailing-twelve-month debt repayment was $0.
Context
- Debt repayment amounted to 0.0% of revenue in FY2025, down 166.6 pp from a year earlier.
- Debt repayment increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly debt repayment holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 5.82M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Debt Repayment vs competitors
How DYAI compares with its peers on the latest reported figures
- Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +100.0% is the 3rd highest of 4, against a peer median of +200.0%.
- Debt repayment amounts to 0.0% of revenue for DYAI, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $8.48M USD | -219.4% | — | 31.9% | |
| LTM Mar 2026 | $4.22M USD | +200.0% | +674.3% | — | |
| FY2025 | A$127.1K AUD | +1125.6% | +54.4% | 2.3% | |
| LTM Mar 2026 | $0 USD | +100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Dec 2025 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding DYAI) | — | +200.0% | +364.4% | 2.3% | |
Competitors are the stored peer set for DYAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (13.07M) | (9.74M) | (6.8M) | (5.81M) | (7.36M) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | (24.17K) |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.78M | 1.89M | 1.24M | 1.13M | 930.18K |
| Change in Working Capital | 1.19M | (321.17K) | (143.21K) | 754.53K | 660.8K |
| Accounts Receivables | (13.92K) | (47.18K) | (93.13K) | 205.26K | (857.85K) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 549.56K | (248.13K) | (651.17K) | (180.18K) | 314.45K |
| Other Working Capital | 652.59K | (25.87K) | 601.09K | 729.45K | 1.2M |
| Other Non-Cash Items | (1.18M) | 83.71K | (1.03M) | (46.45K) | 95.6K |
| Operating Cash Flow | (11.28M) | (8.08M) | (6.73M) | (3.97M) | (5.7M) |
| Capital Expenditures | 0 | 0 | 0 | (4) | 0 |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (11.28M) | (9.87M) | (3M) | (7.34M) | (5.95M) |
| Sales of Investments | 16.51M | 7.5M | 10.45M | 5.47M | 6.03M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 5.22M | (2.37M) | 7.45M | (1.88M) | 82.09K |
| Debt Repayment | 0 | 0 | 0 | 5.82M | 0 |
| Common Stock Issued | 0 | 0 | 0 | 24.25K | 4.96M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.23M | 543.59K | 0 | 0 | 0 |
| Financing Cash Flow | 1.23M | 543.59K | 0 | 5.85M | 4.96M |
| Effect of Forex Changes | (63.26K) | (44.74K) | (2.39K) | (5.8K) | 1.94K |
| Net Change in Cash | (4.89M) | (9.95M) | 720.76K | (8.28K) | (653.25K) |
| Free Cash Flow | (11.28M) | (8.08M) | (6.73M) | (3.97M) | (5.7M) |
Dyadic International, Inc.
NASDAQ:DYAI
Intrinsic Alpha fair value
Locked
Current Price
$1.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.